ConMed acquires MedShape’s ExoShape ACL portfolio |

ConMed acquires MedShape’s ExoShape ACL portfolio

MedShape deals ExoShape ACL portfolio to ConMed (MassDevice)

MedShape said today it inked a deal to divest its ExoShape ACL fixation system properties to ConMed (NSDQ:CNMD) for an undisclosed amount.

The deal, which closed on Monday, includes Atlanta-based MedShape’s ExoShape femoral and tibial soft tissue fasteners designed to fixate soft tissue grafts in anterior cruciate ligament reconstructive surgery.

“The ExoShape system has represented a valuable portion of MedShape’s business since 2011, and this acquisition further demonstrates the success of the development and commercialization efforts invested in the product. While we will certainly miss serving our patients, doctors and distributors with this product line, we look forward to focusing our efforts towards growing our core foot and ankle business with new investments,” CEO Kurt Jacobus said in a press release.

The ExoShape ACL fixation system is manufactured out of shape memory PEEK Altera, with low-profile shaped fasteners for easy insertion which expand upon deployment to compress and secure soft tissue inside the bone tunnel, MedShape said.

In April, ConMed inked a licensing agreement with KFx Medical for its knotless double row rotator cuff repair patents. Through the agreement, ConMed and its subsidiaries will have the right to market products and techniques for knotless double row rotator cuff repair.